Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TSPO | P30536 | 6/20 | 0.40 |
| ▸ | ICMT | O60725 | 5/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.35 |
| ▸ | IGF1R | P08069 | 1/20 | 0.35 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.35 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.35 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.34 |
| ▸ | USP14 | P54578 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8928141 | 0.91 | KDM4E (0.46) | KDM4EATML3MBTL1TSPOICMT | |
| SCHEMBL10309939 | 0.91 | KDM4E (0.50) | KDM4EATML3MBTL1TSPOPTPN1 | |
| SCHEMBL15306423 | 0.90 | L3MBTL1 (0.53) | KDM4EATML3MBTL1TSPOPTPN1 | |
| SCHEMBL14183847 | 0.90 | L3MBTL1 (0.49) | KDM4EATML3MBTL1TSPOPTPN1 | |
| SCHEMBL13969285 | 0.90 | L3MBTL1 (0.53) | KDM4EATML3MBTL1TSPOPTPN1 | |
| SCHEMBL10004856 | 0.90 | L3MBTL1 (0.53) | KDM4EATML3MBTL1TSPOPTPN1 | |
| SCHEMBL15306455 | 0.90 | L3MBTL1 (0.53) | KDM4EATML3MBTL1TSPOPTPN1 | |
| SCHEMBL10309971 | 0.90 | L3MBTL1 (0.49) | KDM4EATML3MBTL1TSPOPTPN1 | |
| SCHEMBL13130948 | 0.90 | L3MBTL1 (0.49) | KDM4EATML3MBTL1TSPOPTPN1 | |
| SCHEMBL13803226 | 0.90 | L3MBTL1 (0.49) | KDM4EATML3MBTL1TSPOPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9732036-B2 | Compound having carbazole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-08-15 | — | — | US | disclosed |
| US-20120175599-A1 | COMPOUND HAVING CARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120175599-A1 | COMPOUND HAVING CARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | POU5F1, POU2F1, KCNH3 | KDM4E 1981/4885ATM 4605/4885L3MBTL1 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.